Citigroup
AGL icon

Citigroup’s Agilon Health AGL Stock Holding History

Citigroup’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
5,935
+5,366
+943% +$351K ﹤0.01% 3771
2026
Q1 		$4.5K Buy
569
+226
+66% +$3.65K ﹤0.01% 5287
2025
Q4 		$5.91K Sell
343
-1,107
-76% -$21.5K ﹤0.01% 5197
2025
Q3 		$37.3K Sell
1,450
-3,712
-72% -$140K ﹤0.01% 4582
2025
Q2 		$297K Sell
5,162
-4,574
-47% -$367K ﹤0.01% 3884
2025
Q1 		$1.05M Sell
9,736
-777
-7% -$67.6K ﹤0.01% 3226
2024
Q4 		$499K Sell
10,513
-70,617
-87% -$4.27M ﹤0.01% 3829
2024
Q3 		$7.97M Buy
81,130
+77,680
+2,252% +$10M ﹤0.01% 1474
2024
Q2 		$564K Sell
3,450
-3,520
-51% -$501K ﹤0.01% 3314
2024
Q1 		$1.06M Buy
6,970
+6,685
+2,346% +$1.11M ﹤0.01% 2972
2023
Q4 		$89.4K Sell
285
-763
-73% -$276K ﹤0.01% 4242
2023
Q3 		$465K Buy
1,048
+742
+242% +$335K ﹤0.01% 3121
2023
Q2 		$133K Sell
306
-3,446
-92% -$1.94M ﹤0.01% 4102
2023
Q1 		$2.23M Buy
3,752
+3,427
+1,054% +$1.92M ﹤0.01% 1944
2022
Q4 		$131K Sell
325
-142
-30% -$66.6K ﹤0.01% 3916
2022
Q3 		$273K Sell
467
-253
-35% -$151K ﹤0.01% 3616
2022
Q2 		$393K Buy
720
+37
+5% +$18.7K ﹤0.01% 3407
2022
Q1 		$433K Buy
683
+264
+63% +$136K ﹤0.01% 3608
2021
Q4 		$283K Buy
419
+207
+98% +$126K ﹤0.01% 4156
2021
Q3 		$139K Sell
212
-57
-21% -$48.7K ﹤0.01% 4286
2021
Q2 		$273K Buy
+269
New +$236K ﹤0.01% 4075

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citigroup's AGL Position: Q2 2026 in Review

Citigroup increased its Agilon Health (AGL) stake by 943% in Q2 2026, buying an estimated $351K and bringing the position to 5,935 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #3771.

Citigroup first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.97M in Q3 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Citigroup held 5,935 shares of Agilon Health worth $636K as of Q2 2026.
  • Citigroup bought 5,366 Agilon Health shares in Q2 2026, an estimated $351K.
  • Agilon Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3771 holding.
  • Citigroup first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Citigroup's Agilon Health position peaked at $7.97M in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.